AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brynes, A. E
Right arrow Articles by Frost, G. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brynes, A. E
Right arrow Articles by Frost, G. S
Agricola
Right arrow Articles by Brynes, A. E
Right arrow Articles by Frost, G. S
American Journal of Clinical Nutrition, Vol. 72, No. 5, 1111-1118, November 2000
© 2000 American Society for Clinical Nutrition


Original Research Communication

Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes1,2,3

Audrey E Brynes, C Mark Edwards, Arvind Jadhav, Mohammed A Ghatei, Stephen R Bloom and Gary S Frost

1 From the Nutrition and Dietetic Research Group, the Endocrine Unit, and the Lipoprotein Team, Imperial College School of Medicine, Hammersmith Hospital, London.

Background: Polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) have been shown to positively affect blood lipids; however, their comparative effects on insulin sensitivity are unclear.

Objective: Our objective was to investigate whether chronic intake of MUFAs or PUFAs improves insulin sensitivity in people with type 2 diabetes via stimulation of the endogenous gut hormone glucagon-like peptide 1 [7–36] amide (GLP-1).

Design: Nine overweight people with type 2 diabetes received isoenergetic high-MUFA (20.3 ± 3.5% of total energy) or high-PUFA (13.4 ± 1.3%) diets for 24 d in a randomized, double-blind crossover design.

Results: Weight and glycemic control remained stable throughout the study. Despite a significant change in the plasma triacylglycerol linoleic-oleic acid ratio (L:O) with both diets (MUFA: from 0.46 ± 0.03 to 0.29 ± 0.02, P < 0.005; PUFA: from 0.36 ± 0.04 to 0.56 ± 0.05, P < 0.05) and the phospholipid L:O (1.7 ± 0.1 to 2.0 ± 0.3; P = 0.04) during consumption of the PUFA diet, this change was not associated with a change in insulin sensitivity, measured by the short-insulin-tolerance test. There was a significant reduction in the ratio of total to HDL cholesterol during consumption of the PUFA diet (5.2 ± 0.4 compared with 4.7 ± 0.3; P = 0.005) but no change with the MUFA diet. There was no change in the fasting or postprandial incremental area under the curve in response to an identical standard test meal for glucose, insulin, triacylglycerol, nonesterified fatty acids, or GLP-1.

Conclusions: Over the 3-wk intervention period, diet-induced change in the triacylglycerol or phospholipid L:O was not associated with either increased stimulation of GLP-1 or a change in insulin sensitivity in people with type 2 diabetes.

Key Words: MUFA • PUFA • insulin sensitivity • GLP-1 • type 2 diabetes • monounsaturated fatty acids • polyunsaturated fatty acids • glucagon-like peptide 1 [7–36] amide • triacylglycerol • cholesterol




This article has been cited by other articles:


Home page
J. Nutr.Home page
C.-W. Chen and H.-H. Cheng
A Rice Bran Oil Diet Increases LDL-Receptor and HMG-CoA Reductase mRNA Expressions and Insulin Sensitivity in Rats with Streptozotocin/Nicotinamide-Induced Type 2 Diabetes
J. Nutr., June 1, 2006; 136(6): 1472 - 1476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. D. Dworatzek, R. A Hegele, and T. M. Wolever
Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1110 - 1117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Thomsen, H. Storm, J. J Holst, and K. Hermansen
Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 605 - 611.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. C. Lovejoy, S. R. Smith, C. M. Champagne, M. M. Most, M. Lefevre, J. P. DeLany, Y. M. Denkins, J. C. Rood, J. Veldhuis, and G. A. Bray
Effects of Diets Enriched in Saturated (Palmitic), Monounsaturated (Oleic), or trans (Elaidic) Fatty Acids on Insulin Sensitivity and Substrate Oxidation in Healthy Adults
Diabetes Care, August 1, 2002; 25(8): 1283 - 1288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Garaulet, F. Perez-Llamas, M. Perez-Ayala, P. Martinez, F. S. de Medina, F. J Tebar, and S. Zamora
Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity
Am. J. Clinical Nutrition, November 1, 2001; 74(5): 585 - 591.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The American Society for Nutrition